Patents by Inventor Pepa ORTIZ SERRANO

Pepa ORTIZ SERRANO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Strain of subsp. lactis CECT 8145 and use thereof for the treatment and/or prevention of excess weight and obesity and associated diseases
    Patent number: 10946051
    Abstract: The invention is applicable within the food and pharmaceutical industry. More specifically, it relates to a novel strain of the species Bifidobacterium animalis subsp. lactis CECT 8145, the cell components, metabolites and secreted molecules thereof, which, incorporated into food and/or pharmaceutical formulations, can be used in the treatment and/or prevention of excess weight and obesity and related diseases such as metabolic syndrome, hypertension, glycemia, inflammation, type 2 diabetes, cardiovascular diseases, hypercholesterolemia, hormonal alterations, infertility, etc.
    Type: Grant
    Filed: July 17, 2014
    Date of Patent: March 16, 2021
    Assignee: BIOPOLIS, S.L.
    Inventors: Patricia Martorell Guerola, Mª Empar Chenoll Cuadros, Daniel Ramón Vidal, Pepa Ortiz Serrano, Silvia Llopis Pla, Núria Gonzalez Martínez, Salvador Genovés Martínez, Beatriz Casinos Ramo, Ángela Silva Angulo, Amaya Aleixandre
  • NOVEL STRAIN OF BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS CECT 8145 AND USE THEREOF FOR THE TREATMENT AND/OR PREVENTION OF EXCESS WEIGHT AND OBESITY AND ASSOCIATED DISEASES
    Publication number: 20160143963
    Abstract: The invention is applicable within the food and pharmaceutical industry. More specifically, it relates to a novel strain of the species Bifidobacterium animalis subsp. lactis CECT 8145, the cell components, metabolites and secreted molecules thereof, which, incorporated into food and/or pharmaceutical formulations, can be used in the treatment and/or prevention of excess weight and obesity and related diseases such as metabolic syndrome, hypertension, glycemia, inflammation, type 2 diabetes, cardiovascular diseases, hypercholesterolemia, hormonal alterations, infertility, etc.
    Type: Application
    Filed: July 17, 2014
    Publication date: May 26, 2016
    Inventors: Patricia MARTORELL GUEROLA, Mª Empar CHENOLL CUADROS, Daniel RAMÓN VIDAL, Pepa ORTIZ SERRANO, Silvia LLOPIS PLA, Núria GONZALEZ MARTÍNEZ, Salvador GENOVÉS MARTÍNEZ, Beatriz CASINOS RAMO, Ángela SILVA ANGULO, Amaya ALEIXANDRE